No immediate trading catalyst. Monitor for any shareholder proposals or director nominations ahead of the July deadlines, which could signal activist interest. The addition of a Medtronic executive to the board may strengthen operational ties, but no deal or material change is announced.
Price Chart
Executive Summary
MiniMed Group expanded its board from nine to 11 members, appointing David Endicott (CEO of Alcon) and Linnea Burman (SVP at Medtronic) as independent directors. The filing also sets the 2026 annual meeting for October 9, 2026, with advance notice deadlines for shareholder proposals and director nominations. These are routine governance and scheduling updates with no material financial impact.
Key Facts
- Board size increased from 9 to 11 directors.
- David Endicott (CEO of Alcon) appointed as Class I director, effective June 29, 2026.
- Linnea Burman (SVP & President, Neurovascular at Medtronic) appointed as Class II director, effective June 29, 2026.
- 2026 annual meeting set for October 9, 2026, virtually; record date is August 11, 2026.
- Shareholder proposals under Rule 14a-8 due by July 26, 2026; director nominations and other business due by July 17, 2026.
Financial Impact
No financial figures disclosed; director compensation is consistent with existing non-employee director compensation plan.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078588 |
| Document: 0001104659-26-078588-index-headers.html | 0001104659-26-078588 |
| Document: 0001104659-26-078588-index.html | 0001104659-26-078588 |
| Document: 0001104659-26-078588.txt | 0001104659-26-078588 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 14, 2026 18d ago | S-4 / 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.55 (−11.02%) |
Sep 1, 2026 4w ago | 8-K | $22.42 $22.76 | ▲ +1.52% | ▲ +1.44% | $19.55 (−12.80%) |
Jul 6, 2026 12w ago | 3 | $15.37 $15.04 | ▼ −2.15% | ▼ −2.70% | $19.55 (+27.20%) |
Jun 29, 2026 13w ago | 8-K | $14.88 $15.29 | ▲ +2.76% | ▲ +1.37% | $19.55 (+31.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access